Medtronic (NYSE:MDT) touted European regulatory approval and commercial launch for the latest in the company’s line of cervical cages, the Compact CORNERSTONE-SR Alliance.
The new cages, used to treat disc diseases affecting the neck, are the product of of Medtronic’s acquisition of Advanced Medical Technologies, a deal that closed last year, the company said.
Medtronic’s new cervical implants are designed to provide stability during cervical spinal fusion procedures, of which there are more than 44,000 in Europe, the medtech giant said. The device’s commercial launch was timed to coincide with this year’s Eurospine conference in Liverpool, U.K., where the company was on-hand to introduce the new device.
"Anterior cervical spine surgeries remain commonplace and it’s important to bring innovation to this market," Medtronic spinal & biologics vice president for Western Europe and Canada Steve Swinson said in prepared remarks. "With the addition of the CORNERSTONE-SR Alliance cage to our cervical Interbody platform, Medtronic continues to answer the surgeon and hospital needs of today."